{"title":"ART周期中卵泡液和血清抗苗勒管激素水平与妊娠率的关系","authors":"M. Zargar , M. Najafian , Z. Zamanpour","doi":"10.1016/j.rprh.2018.03.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>This study is aimed at determining the serum and follicular fluid level of anti-Mullerian hormone, its quality, and relationship between anti-Mullerian hormone level with assisted reproductive technology (ART) success rates.</p></div><div><h3>Method</h3><p>In 50 infertile patients who underwent the ART cycle, follicular fluid and serum levels of anti-Mullerian hormone were measured on oocyte retrieval day. Patients were then divided into two groups of fertile and non-fertile.</p></div><div><h3>Results</h3><p>Pregnancy test result was positive in 13 and negative in 37 patients. Serum and follicular fluid level of anti-Mullerian hormone was higher among the first group than the second group (<em>P</em> <!--><<!--> <!-->0.05). Mean follicular fluid level of anti-Mullerian hormone was 5.12 and 4.23 among the first and second groups, respectively. Mean serum anti-Mullerian hormone level was 1.76 in the first group and 1.49 in the second group.</p></div><div><h3>Conclusions</h3><p>Higher level of anti-Mullerian hormone in serum and follicular fluid has a significantly positive correlation with the success rate in ART cycles and oocyte quality; therefore, anti-Mullerian hormone can be a positive predictor of ART success cycles.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"32 1","pages":"Pages 3-8"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2018.03.001","citationCount":"2","resultStr":"{\"title\":\"Relationship between follicular fluid and serum anti-Mullerian hormone levels and pregnancy rate in ART cycles\",\"authors\":\"M. Zargar , M. Najafian , Z. Zamanpour\",\"doi\":\"10.1016/j.rprh.2018.03.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>This study is aimed at determining the serum and follicular fluid level of anti-Mullerian hormone, its quality, and relationship between anti-Mullerian hormone level with assisted reproductive technology (ART) success rates.</p></div><div><h3>Method</h3><p>In 50 infertile patients who underwent the ART cycle, follicular fluid and serum levels of anti-Mullerian hormone were measured on oocyte retrieval day. Patients were then divided into two groups of fertile and non-fertile.</p></div><div><h3>Results</h3><p>Pregnancy test result was positive in 13 and negative in 37 patients. Serum and follicular fluid level of anti-Mullerian hormone was higher among the first group than the second group (<em>P</em> <!--><<!--> <!-->0.05). Mean follicular fluid level of anti-Mullerian hormone was 5.12 and 4.23 among the first and second groups, respectively. Mean serum anti-Mullerian hormone level was 1.76 in the first group and 1.49 in the second group.</p></div><div><h3>Conclusions</h3><p>Higher level of anti-Mullerian hormone in serum and follicular fluid has a significantly positive correlation with the success rate in ART cycles and oocyte quality; therefore, anti-Mullerian hormone can be a positive predictor of ART success cycles.</p></div>\",\"PeriodicalId\":32275,\"journal\":{\"name\":\"Perinatologia y Reproduccion Humana\",\"volume\":\"32 1\",\"pages\":\"Pages 3-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rprh.2018.03.001\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Perinatologia y Reproduccion Humana\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0187533718300062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perinatologia y Reproduccion Humana","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0187533718300062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Relationship between follicular fluid and serum anti-Mullerian hormone levels and pregnancy rate in ART cycles
Objective
This study is aimed at determining the serum and follicular fluid level of anti-Mullerian hormone, its quality, and relationship between anti-Mullerian hormone level with assisted reproductive technology (ART) success rates.
Method
In 50 infertile patients who underwent the ART cycle, follicular fluid and serum levels of anti-Mullerian hormone were measured on oocyte retrieval day. Patients were then divided into two groups of fertile and non-fertile.
Results
Pregnancy test result was positive in 13 and negative in 37 patients. Serum and follicular fluid level of anti-Mullerian hormone was higher among the first group than the second group (P < 0.05). Mean follicular fluid level of anti-Mullerian hormone was 5.12 and 4.23 among the first and second groups, respectively. Mean serum anti-Mullerian hormone level was 1.76 in the first group and 1.49 in the second group.
Conclusions
Higher level of anti-Mullerian hormone in serum and follicular fluid has a significantly positive correlation with the success rate in ART cycles and oocyte quality; therefore, anti-Mullerian hormone can be a positive predictor of ART success cycles.
期刊介绍:
Perinatología y Reproducción Humana is the official journal of the Instituto Nacional de Perinatología, Mexico. It is aimed at physicians of the area of perinatal and reproductive health (obstetrics and gynecology, maternal and fetal medicine, pediatricians, neonatologists, endocrinologists, infectious disease specialists, and neurologists) and also at health sciences professionals involved in the study of reproduction perinatal and reproductive health (chemists, biologists and neuro-physiologists). It is an electronic biannual journal, that publishes peer-reviewed original articles, in-deep reviews, letters to the editor and special sections related to basic, epidemiological, surgical, and clinical aspects in the area of perinatal and reproductive health, in English or Spanish languages and open access.